Craig A. Drill’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Craig A. Drill’s Portfolio PTX Stock Details PTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-8,760	Closed	-$936K	–	29
2015 Q1	$936K	Buy	+8,760	New	+$835K	1.06%	17
2014 Q2	–	Sell	-3,710	Closed	-$198K	–	33
2014 Q1	$198K	Buy	+3,710	New	+$122K	0.25%	28

Other funds holding PTX

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

ECP

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

WSA

Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return

RCMC

RK Capital Management (Colorado) Denver, Colorado $324K AUM 47.52% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Craig A. Drill's PTX Position: Q2 2015 in Review

Craig A. Drill sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q2 2015, closing a stake of 8,760 shares — an estimated $936K sold.

Craig A. Drill first reported a position in PTX in Q1 2014 and held it in 2 quarters. The position peaked at $936K in Q1 2015. 114 funds tracked by Wall St. Rank hold PTX as of Q2 2015.

Craig A. Drill reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q2 2015 after selling out during the quarter.
Craig A. Drill sold 8,760 Pernix Therapeutics Holdings, Inc. shares in Q2 2015, an estimated $936K.
Craig A. Drill first reported a position in Pernix Therapeutics Holdings, Inc. in Q1 2014 and held it in 2 quarters.
Craig A. Drill's Pernix Therapeutics Holdings, Inc. position peaked at $936K in Q1 2015.
114 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q2 2015.

Based on Craig A. Drill's 13F filing for Q2 2015, filed 11 Aug 2015.